Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Addiction Medicine|April 4, 2015
Acute hyperkinetic syndrome due to ephedrone abuseAnna Dolgan, Slawomir Budrewicz, Magdalena Koszewicz, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 23, 2015
The possible meaning of fractional anisotropy measurement of the cervical spinal cord in correct diagnosis of amyotrophic lateral sclerosisSlawomir Budrewicz, Pawel Szewczyk, Joanna Bladowska, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 11, 2008
Mild cognitive impairment and event-related potentials in patients with cerebral atrophy and leukoaraiosisRyszard Podemski, Anna Pokryszko-Dragan, Mieszko Zagrajek, et al.
Breast Cancer Research and Treatment|September 14, 2007
Antibodies to 46-kDa retinal antigen in a patient with breast carcinoma and cancer-associated retinopathyMaria Ejma, Marta Misiuk-Hojło, Wojciech A Gorczyca, et al.
Journal of the Neurological Sciences|January 29, 2014
Magnetic resonance spectroscopy findings as related to fatigue and cognitive performance in multiple sclerosis patients with mild disabilityAnna Pokryszko-Dragan, Joanna Bladowska, Anna Zimny, et al.
Neurologia I Neurochirurgia Polska|June 4, 2004
[Open trial of the effectiveness of interferon beta 1a (Avonex) in the treatment of multiple sclerosis in Poland: MRI results]Małgorzata Siger-Zajdel, Magdalena Lewańska, Krzysztof Zaleski, et al.
Journal of Neuroimmunology|March 13, 2017
PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MSEdyta Pawlak-Adamska, Oskar Nowak, Lidia Karabon, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 23, 2002
An open-label study to evaluate the safety, tolerability and efficacy of rivastigmine in patients with mild to moderate probable Alzheimer's disease in the community settingAdam Bilikiewicz, Grzegorz Opala, Ryszard Podemski, et al.
Journal of Lipid Research|August 10, 2020
Distinctive sphingolipid patterns in chronic multiple sclerosis lesionsMaria Podbielska, Zdzislaw M Szulc, Toshio Ariga, et al.
Pageof 4